30 March 2021
Rymarz Zdort advised ExploRNA Therapeutics in the process of an equity investment that involved a subscription for shares in ExploRNA Therapeutics by the fund Black Forest SICAV-SIF (owned by Michał Sołowow) and the provision of funds for the expansion of the former’s operations.
ExploRNA Therapeutics is a biotech spin-off company of the University of Warsaw, which develops ground-breaking mRNA modification technologies paving the way for new therapeutic applications of mRNA in medicine, such as COVID-19 vaccines.
Black Forest SICAV-SIF is an investment fund supporting scientific and technological advancements achieved by both Polish and foreign companies. Active in a number of industries and sectors, Black Forest’s net asset value has now exceeded EUR 4.1 billion. Products manufactured by its companies are sold throughout the world (in more than 60 countries, in six continents).
The investment by Black Forest SICAV-SIF will allow ExploRNA Therapeutics to develop and implement an ambitious research program focusing on the use of mRNA for therapeutic purposes and enhancing the company’s research potential.
1 April 2026
We are pleased to announce that we advised ZDROWIT S.A. on its financing of an amount of up to PLN 400 million. The financing was provided by Bank Pekao S.A., PKO Bank Polski S.A. and mBank S.A., with...
31 March 2026
We are pleased to announce that we advised Volkswagen Financial Services Polska sp. z o.o. on the issuance of 2-year secured fixed coupon bonds with a value of PLN 200,000,000...
26 March 2026
We are pleased to announce that we advised BEST S.A. on the establishment of a public bond issuance programme for up to PLN 500 million or the equivalent amount in EUR, on the preparation of the prosp...
25 March 2026
This year’s edition of The Legal 500 EMEA ranking has confirmed Rymarz Zdort Maruta’s position as one of the leading law firms in the market. We have been recognised in 17 practice areas, and 23 of ou...
25 March 2026
We are pleased to announce that we advised VECTRA S.A., a leading telecommunications services provider and the largest cable operator in Poland, and its subsidiaries on financing provided by a consort...
23 March 2026
We are pleased to announce that we advised Czechoslovak Group (“CSG”), one of Europe’s largest defence groups, on the acquisition of Domar sp. z o.o., a Polish distributor and manufacturer of electric...
19 March 2026
In this year’s edition of the Chambers and Partners Europe ranking, 14 practices of Rymarz Zdort Maruta have been recognised, including two new practice areas, and a total of 23 recognitions were awar...
9 March 2026
We are pleased to announce that Rymarz Zdort Maruta partners Jacek Zawadzki and Piotr Fedorowicz have been named among the Top 10 M&A Lawyers in CEE according to the latest MergerLinks ranking. Ja...
17 February 2026
We are pleased to announce that we advised the majority shareholders of OSHEE Polska S.A. (“OSHEE”), including its founders Dariusz Gałęzewski and Dominik Doliński, in connection with the exit of Inno...
16 February 2026
We are pleased to announce that we advised DUON Dystrybucja sp. z o.o. in connection with the conclusion of an agreement with PAK CCGT sp. z o.o., a subsidiary of ZE PAK S.A., ensuring the supply of g...
12 February 2026
Five recognised practices are not only a source of pride for us, but also confirmation that we consistently deliver value to our clients, which is also reflected in global rankings. Recognised prac...
28 January 2026
We are pleased to announce that we advised the Grant Thornton Advisors platform on the addition of Grant Thornton Polska to the multinational platform that it formed in 2025 with support from a group ...
9 January 2026
Mergermarket has published its global and regional rankings of legal advisors in the field of mergers and acquisitions for 2025 – Global and Regional M&A Rankings 2025 – Legal Advisors. This annua...
